Publisher Correction: Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker
Clinical Epigenetics volume 15, Article number: 3 (2023)
Correction to: Clinical Epigenetics (2022) 14:148 https://doi.org/10.1186/s13148-022-01362-z
Following publication of the original article , the author noticed an error in the figure. In the published version, the image of Fig. 5 has been repeated twice. The author has informed to remove the duplicated image during correction process. The typesetter has inadvertently missed to correct the figure. However, the text citation and caption of the figure seem to be correct. The corrected Fig. 5 has been published with this erratum.
The original has been corrected.
Bigouret V, Hoffmann T, Arlettaz L, Villard J, Colonna M, Ticheli A, et al. Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors. Blood. 2003;101:3198–204.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Johansson, P., Laguna, T., Ossowski, J. et al. Publisher Correction: Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker. Clin Epigenet 15, 3 (2023). https://doi.org/10.1186/s13148-022-01405-5